SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-19-008082
Filing Date
2019-04-26
Accepted
2019-04-26 17:33:42
Documents
2
Period of Report
2019-04-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1365
2 geffkenpoa.htm EX-24 9368
  Complete submission text file 0001437749-19-008082.txt   12496
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Issuer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address DAMONMILL SQUARE SUITE 6A CONCORD MA 01742
Business Address
Geffken Daniel E. (Reporting) CIK: 0001314756 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26422 | Film No.: 19773021